Haemophagocytic lymphohistiocytosis complicating typhoid fever: A case report from Senegal Authors: Mourno Tarsa Nousradine, Omar Boun Khatab Diouf, Michel Assane Ndour, Abou Koundio, Mouhamed Dieng, Melissa D’Erneville, Stive Denilson Padounendji, Abel Ndongar, Khadim Mbow, Abilhabibi Ahamadi, Anna Sarr, Maimouna Ndour Mbaye Published: 2026 ABSTRACT We report a case of secondary haemophagocytic lymphohistiocytosis (HLH) triggered by confirmed typhoid fever (Salmonella Typhi) in a 23-year-old Senegalese man. The initial radiological presentation suggested ileo-caecal tuberculosis. Thus, persistent fever, marked hyperferritinaemia and systemic inflammation raised suspicion of HLH, confirmed by bone marrow examination demonstrating hemophagocytosis. The H-Score was 206, corresponding to 88–93% probability. Blood cultures isolated ciprofloxacin-susceptible Salmonella Typhi. Fluoroquinolone monotherapy led to complete clinical and biological remission without the need for immunosuppression. This case underscores the importance of including typhoid fever in the differential aetiology of HLH in endemic settings, and of early H-Score calculation to expedite diagnosis. Introduction Haemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome driven by uncontrolled activation of cytotoxic T lymphocytes and macrophages, culminating in a cytokine storm and potential multi-organ failure [1], [2]. Secondary HLH most commonly arises in the context of viral infections, principally Epstein–Barr virus (EBV), but bacterial, parasitic, and fungal triggers are well recognised [1]. Enteric fever, caused by Salmonella Typhi or S. Paratyphi, remains a major public health burden in low- and middle-income countries, with complications occurring in 10–15% of cases [3]. The co-occurrence of HLH and typhoid fever is exceptionally rare: a 2024 systematic review identified only 53 reported cases worldwide, with a single case documented in Africa [4]. We present a case from Senegal in which this association was initially obscured by an imaging phenotype mimicking ileo-caecal tuberculosis, and in which aetiological antibiotic therapy alone achieved full remission. Case presentation A 23-year-old Senegalese man, employed as a minibus driver's apprentice, was admitted with a two-week history of high-grade fever with rigors, profuse night sweats, non-bloody watery diarrhoea with mucus, post-prandial vomiting, headache, insomnia, marked asthenia, anorexia, and a 10 kg weight loss. He had no history of tuberculosis contact, alcohol or tobacco use, or herbal remedy intake. On examination, oral temperature was 40°C, all other vital signs were within normal limits. Abdominal palpation revealed hepatomegaly and diffuse guarding with point tenderness in the right iliac fossa. There were no lymphadenopathy, splenomegaly, jaundice, skin lesions, or overt haemorrhage. Baseline investigations (Table 1) showed haemoglobin 12.3 g/dL, persistent leuconeutropenia (neutrophils 1.8 × 10⁹/L), markedly elevated C-reactive protein (167.4 mg/L), ferritin 7153 ng/mL, LDH 832 U/L, hypofibrinogenaemia (190 mg/dL), and significant hepatocytolysis (AST 7.5 × ULN; ALT 9 × ULN). Triglycerides were within the normal range at 69 mg/L. Renal function and serum electrolytes were normal.Table 1Summary of laboratory investigations at admission (Day 1) and after five days of fluoroquinolone therapy (Day 5).ParameterDay 1Day 5Reference rangeComplete blood countHaemoglobin (g/dL)12.313.413–18White blood cells (×10⁹/L)4.26.384–10Neutrophils (×10⁹/L)1.83.81.5–7.5Lymphocytes (×10⁹/L)2.11.56—Platelets (×10⁹/L)232427150–400Inflammatory markersCRP (mg/L)167.412.3< 6LDH (U/L)832—207–414Ferritin (ng/mL)7153—30–300Fibrinogen (mg/dL)190—200–400Triglycerides (mg/L)69—< 150Liver functionAST (U/L)31837< 40ALT (U/L)28625< 30Prothrombin time (%)7382> 70Renal functionUrea (g/L)0.110.130.15–0.45Creatinine (mg/L)9.4111.25–15Serum electrolytesSodium (mmol/L)135—135–145Potassium (mmol/L)3.8—3.5–5.3Chloride (mmol/L)96—95–105AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein; LDH, lactate dehydrogenase; ULN, upper limit of normal. Table 1Summary of laboratory investigations at admission (Day 1) and after five days of fluoroquinolone therapy (Day 5).ParameterDay 1Day 5Reference rangeComplete blood countHaemoglobin (g/dL)12.313.413–18White blood cells (×10⁹/L)4.26.384–10Neutrophils (×10⁹/L)1.83.81.5–7.5Lymphocytes (×10⁹/L)2.11.56—Platelets (×10⁹/L)232427150–400Inflammatory markersCRP (mg/L)167.412.3< 6LDH (U/L)832—207–414Ferritin (ng/mL)7153—30–300Fibrinogen (mg/dL)190—200–400Triglycerides (mg/L)69—< 150Liver functionAST (U/L)31837< 40ALT (U/L)28625< 30Prothrombin time (%)7382> 70Renal functionUrea (g/L)0.110.130.15–0.45Creatinine (mg/L)9.4111.25–15Serum electrolytesSodium (mmol/L)135—135–145Potassium (mmol/L)3.8—3.5–5.3Chloride (mmol/L)96—95–105AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein; LDH, lactate dehydrogenase; ULN, upper limit of normal. Summary of laboratory investigations at admission (Day 1) and after five days of fluoroquinolone therapy (Day 5). AST, aspartate aminotransferase; ALT, alanine aminotransferase; CRP, C-reactive protein; LDH, lactate dehydrogenase; ULN, upper limit of normal. Abdominal ultrasound, performed one week before admission, demonstrated circumferential hyperechoic mural thickening of the terminal ileum and caecum with Doppler hypervascularisation, infiltration of adjacent mesenteric fat, and mesenteric lymphadenopathy (dominant node: 14 mm short axis), a pattern interpreted as suggestive of ileo-caecal tuberculosis. Abdominal computed tomography corroborated these findings, showing supra-inflammatory parietal thickening of the terminal ileum and rectum, peritoneal effusion, mesenteric and peri-ileo-caecal lymphadenopathy, and homogeneous hepatomegaly (hepatic height 169.5 mm) without focal lesions (Fig. 1).Fig. 1Abdominal CT scan: Circumferential parietal wall thickening with stenosing involvement of the terminal ileum and rectum (yellow and white arrows). Right mesenteric and pericolic lymphadenopathies, with the largest measuring 13.1 × 26.7 mm and 13.5 × 4.4 mm. Hepatomegaly (liver height = 169.5 mm), with normal morphology and no focal suspicious lesions (red arrow). Abdominal CT scan: Circumferential parietal wall thickening with stenosing involvement of the terminal ileum and rectum (yellow and white arrows). Right mesenteric and pericolic lymphadenopathies, with the largest measuring 13.1 × 26.7 mm and 13.5 × 4.4 mm. Hepatomegaly (liver height = 169.5 mm), with normal morphology and no focal suspicious lesions (red arrow). Given the persistence of fever despite paracetamol, metamizole, along with empirical ceftriaxone treatment, therapy, secondary HLH was suspected. Ferritin, LDH, and fibrinogen levels confirmed a state of systemic hyperinflammation. Bone marrow aspirate revealed a normocellular marrow (grade III) with a predominant granulocytic lineage, near-absent erythropoiesis, rare megakaryocytes, and multiple macrophages displaying active haemophagocytosis of red cells, leucocytes, and platelets (Fig. 2). The H-Score was 206, corresponding to an 88–93% probability of HLH.Fig. 2Bone marrow aspirate findings: Normocellular bone marrow (type III), slightly diluted, characterized by the presence of rare megakaryocytes. The granulocytic lineage is predominant and shows no significant morphological abnormalities. The lymphoid lineage is also well represented. The erythroid lineage is nearly absent. Additionally, there is the presence of activated macrophages with tangible bodies, associated with numerous images of hemophagocytosis. Bone marrow aspirate findings: Normocellular bone marrow (type III), slightly diluted, characterized by the presence of rare megakaryocytes. The granulocytic lineage is predominant and shows no significant morphological abnormalities. The lymphoid lineage is also well represented. The erythroid lineage is nearly absent. Additionally, there is the presence of activated macrophages with tangible bodies, associated with numerous images of hemophagocytosis. Aetiological workup was systematic. Thick blood film, Quantitative Buffy Coat (QBC) for haemoparasites and Borrelia spp., HIV serology, HBsAg, anti-HBc, anti-HCV, anti-HAV IgM, stool microscopy (KAOP method), and stool cultures were all negative. Three sets of blood cultures isolated Salmonella Typhi, susceptible to ciprofloxacin and ceftriaxone (MIC not reported). The patient was treated with oral ciprofloxacin for seven days. Clinical response was rapid: fever resolved within 72 h, gastrointestinal symptoms abated, and repeat blood tests at day 5 demonstrated normalisation of inflammatory markers, transaminases, and blood count (Table 1). No immunosuppressive therapy was required. Discussion Enteric fevers (typhoid and paratyphoid fever) are common febrile illnesses in low-resource settings. Their incidence remains high in Africa, with substantial associated morbidity and mortality [3], [5], [6]. Salmonella Typhi initially invades the gastrointestinal tract before progressing to systemic infection [7]. Severe forms occur in 10–15% of cases and include complications such as myocarditis, intestinal perforation, gastrointestinal hemorrhage, and typhoid encephalopathy [8]. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome characterized by uncontrolled cytokine release leading to multiorgan failure [1], [9]. Infectious triggers are most commonly associated with Epstein–Barr virus (EBV) infection [9]. Diagnosis relies on a combination of clinical and laboratory criteria. The HLH-2004 score, initially developed in pediatrics, is often difficult to apply in resource-limited settings due to the unavailability of key parameters such as soluble IL-2 receptor levels and natural killer (NK) cell activity. The H-score, a more recent tool, provides a probabilistic diagnostic approach with a threshold of 169 points [10], [11], [12]. The association between typhoid fever and HLH remains rare. A 2024 systematic review identified 53 reported cases in the literature, with only one case from Africa [4]. The mean patient age was 18 years, and diagnosis was most frequently established during the third week of illness. Ceftriaxone was the most commonly used antibiotic. Given the rarity of this association, no specific therapeutic guidelines currently exist. In certain infectious contexts such as tuberculosis, leishmaniasis, and rickettsial diseases, etiological treatment alone may be sufficient [13]. However, in the aforementioned review, nearly 50% of patients also received immunosuppressive therapy [4]. The overall mortality rate was 9.4%, with most deaths occurring among patients who required immunosuppression. Our patient achieved full remission with a seven-day course of ciprofloxacin, without recourse to immunosuppression, consistent with the favourable outcomes reported when aetiological therapy is initiated promptly. In the absence of evidence supporting tuberculosis and with confirmed Salmonella Typhi infection, imaging findings were considered likely related to typhoid ileo-caecal involvement. Typhoid fever can involve the ileocaecal region due to lymphoid tissue involvement and may mimic intestinal tuberculosis, especially in endemic areas [14], [15], [16], [17]. Follow-up imaging was not performed due to clinical and biological improvement. Conclusion This case underscores that typhoid fever, although a rare trigger, should be considered in the aetiological workup of HLH in endemic settings particularly in sub-Saharan Africa, where both infections are prevalent. Early H-Score calculation enables timely diagnosis without requiring unavailable assays. Prompt initiation of fluoroquinolone therapy, guided by antibiogram, may achieve complete remission without immunosuppression when HLH is recognised early. Clinicians should also be aware of the potential imaging overlap between typhoid ileocolitis and ileo-caecal tuberculosis, which may delay the correct diagnostic pathway. CRediT authorship contribution statement Abou Koundio: Investigation. Michel Assane Ndour: Writing – review & editing, Validation, Supervision. Melissa D’Erneville: Investigation. Mouhamed Dieng: Validation. Omar Boun Khatab Diouf: Writing – review & editing, Supervision. Mourno Tarsa Nousradine: Writing – review & editing, Writing – original draft, Visualization, Validation, Methodology, Investigation, Conceptualization. Maimouna Ndour Mbaye: Validation. Anna Sarr: Validation. Abel Ndongar: Conceptualization. Stive Denilson Padounendji: Writing – original draft, Conceptualization. Abilhabibi Ahamadi: Conceptualization. Khadim Mbow: Conceptualization. Ethics declaration Written informed consent to take part in the study and to publish the article has been obtained from all participants or their legal representatives. The privacy rights of participants have been observed. This study was performed in compliance with relevant laws, regulatory frameworks and guidelines where the research took place. Ethics committee approval was not required under relevant laws and institutional guidelines. Ethics committee approval was not required. This research follows the CARE guidelines and the CARE checklist. Ethical approval This case report was conducted in accordance with the principles outlined in the Declaration of Helsinki. Consent Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request. Declaration of Generative AI and AI-assisted technologies in the writing process During the preparation of this work the author(s) used ChatGpt in order to transalate. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article. Funding None. Declaration of Competing Interest The authors declare no competing interests.